Noninvasive cardiac stress testing is a cornerstone in the clinical treatment of patients with known or suspected coronary artery disease (CAD).
1,2 Numerous previous reports and meta-analyses have concluded that stress cardiac magnetic resonance imaging (CMR) is more accurate for the diagnosis of CAD compared with conventional stress imaging methods,
3-8 yet CMR represents less than 0.1% of all imaging-based stress tests performed in the United States.
9 Optimal patient treatment relies on both the diagnostic and prognostic information provided by noninvasive testing, and with escalating costs associated with use of advanced imaging methods, there has been a fundamental shift from a simple focus on test accuracy to a broader focus on patient outcome.
10